Cellectis S.A. (EPA:ALCLS)
France flag France · Delayed Price · Currency is EUR
2.542
-0.048 (-1.85%)
Jul 13, 2026, 5:35 PM CET

Cellectis Revenue

Cellectis had revenue of $7.55M USD in the quarter ending March 31, 2026, a decrease of -37.25%. This brings the company's revenue in the last twelve months to $75.11M, up 37.20% year-over-year. In the year 2025, Cellectis had annual revenue of $79.59M with 61.72% growth.

Revenue (ttm)
$75.11M
Revenue Growth
+37.20%
P/S Ratio
2.83
Revenue / Employee
$328.00K
Employees
229
Market Cap
184.55M EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202579.59M30.38M61.72%
Dec 31, 202449.22M40.02M435.37%
Dec 31, 20239.19M-16.53M-64.26%
Dec 31, 202225.72M-12.87M-33.35%
Dec 31, 202138.60M-20.97M-35.20%
Dec 31, 202059.56M36.57M159.09%
Dec 31, 201922.99M1.56M7.27%
Dec 31, 201821.43M-12.28M-36.43%
Dec 31, 201733.72M-22.73M-40.27%
Dec 31, 201656.45M-6.12M-9.78%
Dec 31, 201562.57M30.56M95.47%
Dec 31, 201432.01M14.51M82.92%
Dec 31, 201317.50M-10.25M-36.93%
Dec 31, 201227.74M7.04M34.00%
Dec 31, 201120.70M-248.60K-1.19%
Dec 31, 201020.95M6.11M41.19%
Dec 31, 200914.84M-2.65M-15.16%
Dec 31, 200817.49M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Valneva SE156.33M
Genfit70.85M
Innate Pharma9.01M
Transgene7.21M
Sensorion5.81M
MaaT Pharma4.52M
ABIONYX Pharma4.06M
Adocia3.85M
Revenue Rankings